WO2006080171A1 - 免疫増強剤 - Google Patents
免疫増強剤 Download PDFInfo
- Publication number
- WO2006080171A1 WO2006080171A1 PCT/JP2005/023844 JP2005023844W WO2006080171A1 WO 2006080171 A1 WO2006080171 A1 WO 2006080171A1 JP 2005023844 W JP2005023844 W JP 2005023844W WO 2006080171 A1 WO2006080171 A1 WO 2006080171A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- μιρ
- functional derivative
- emip
- mip
- immunopotentiator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005800475245A CN101119743B (zh) | 2005-01-31 | 2005-12-20 | 免疫增强剂 |
AU2005326226A AU2005326226B2 (en) | 2005-01-31 | 2005-12-20 | Immunopotentiating agent |
CA002596232A CA2596232A1 (en) | 2005-01-31 | 2005-12-20 | The use of emip as cancer therapeutics in combination with electron beam irradiation or adjuvant treatment |
JP2007500440A JPWO2006080171A1 (ja) | 2005-01-31 | 2005-12-20 | 免疫増強剤 |
US11/883,302 US7662781B2 (en) | 2005-01-31 | 2005-12-20 | Immunopotentiating agent |
EP05819441A EP1854474A4 (en) | 2005-01-31 | 2005-12-20 | IMMUNOSTIMULATING AGENT |
HK08103620.4A HK1113463A1 (en) | 2005-01-31 | 2008-04-02 | Immunopotentiating agent |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-023224 | 2005-01-31 | ||
JP2005023224 | 2005-01-31 | ||
JP2005-266381 | 2005-09-14 | ||
JP2005266381 | 2005-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006080171A1 true WO2006080171A1 (ja) | 2006-08-03 |
Family
ID=36740204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/023844 WO2006080171A1 (ja) | 2005-01-31 | 2005-12-20 | 免疫増強剤 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7662781B2 (ja) |
EP (1) | EP1854474A4 (ja) |
JP (1) | JPWO2006080171A1 (ja) |
KR (1) | KR20070099013A (ja) |
CN (1) | CN101119743B (ja) |
AU (1) | AU2005326226B2 (ja) |
CA (1) | CA2596232A1 (ja) |
HK (1) | HK1113463A1 (ja) |
WO (1) | WO2006080171A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | eMIPを有効成分とする水溶性製剤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102017002645A1 (de) | 2017-03-17 | 2018-09-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Bestrahlung von Säugetierzellen mit Elektronenstrahlen und/oder Röntgenstrahlen |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511263A (ja) * | 1993-06-15 | 1996-11-26 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 造血細胞の放出と可動化 |
JP2000157285A (ja) * | 1998-11-30 | 2000-06-13 | Kenji Obara | Ld78遺伝子群ケモカインとホモログペプチド |
JP2004194770A (ja) * | 2002-12-17 | 2004-07-15 | Okumura Yu-Ki Co Ltd | 遊技機 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616688A (en) * | 1981-09-08 | 1997-04-01 | The Rockefeller University | Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
WO1985003934A1 (en) | 1984-03-06 | 1985-09-12 | Takeda Chemical Industries, Ltd. | Chemically modified protein and process for its preparation |
JPS6075499A (ja) | 1983-08-08 | 1985-04-27 | Kuraray Co Ltd | ネオカルチノスタチン誘導体及びその製造法 |
DE3572982D1 (en) | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
US4705955A (en) * | 1985-04-02 | 1987-11-10 | Curt Mileikowsky | Radiation therapy for cancer patients |
ES8800982A1 (es) | 1985-07-05 | 1987-12-01 | Takeda Chemical Industries Ltd | Un metodo para producir la enzima superoxido-dismutasa modificada con derivados de polietilenglicol y triazina. |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
JPH04218000A (ja) | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
JPH06256394A (ja) | 1991-08-13 | 1994-09-13 | Kirin Amgen Delaware Inc | 修飾インターロイキン6 |
AU679436B2 (en) * | 1991-12-23 | 1997-07-03 | British Bio-Technology Limited | Stem cell inhibiting proteins |
US5880131A (en) | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5840900A (en) | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US5977310A (en) * | 1995-03-10 | 1999-11-02 | Toshikazu Nakamura And Sumitomo Pharmaceuticals Co., Ltd. | Peg-modified HGF |
AU1119397A (en) * | 1995-11-14 | 1997-06-05 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
JPH1160499A (ja) | 1997-08-22 | 1999-03-02 | Hiroshi Maeda | 抗腫瘍剤 |
US6168784B1 (en) | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
EP1013276A1 (en) | 1998-12-23 | 2000-06-28 | Pfizer Inc. | Aminoazacycloalkanes as CCR5 modulators |
DE60040651D1 (de) * | 1999-02-12 | 2008-12-11 | Emd Serono Res Ct Inc | Methoden zur behandlung von tumoren und metastasen unter verwendung einer anti-angiogenen und immun-therapien |
CA2383626A1 (en) | 1999-10-15 | 2001-08-02 | Bobby G. Edwards | Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
US7091310B2 (en) | 2002-09-13 | 2006-08-15 | Chemokine Therapeutics Corporation | Chemokine analogs for the treatment of human disease |
AU2001252650A1 (en) | 2000-04-28 | 2001-11-12 | Effector Cell Institute | Novel derivative of cell chemotactic factor |
JP2004196770A (ja) * | 2002-10-24 | 2004-07-15 | Effector Cell Institute Inc | 樹状細胞前駆体の血中レベル上昇剤 |
AU2003291402A1 (en) * | 2002-11-07 | 2004-06-03 | Beth Israel Deaconess Medical Center | MIP-1Alpha AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE |
-
2005
- 2005-12-20 EP EP05819441A patent/EP1854474A4/en not_active Withdrawn
- 2005-12-20 CN CN2005800475245A patent/CN101119743B/zh active Active
- 2005-12-20 WO PCT/JP2005/023844 patent/WO2006080171A1/ja active Application Filing
- 2005-12-20 CA CA002596232A patent/CA2596232A1/en not_active Abandoned
- 2005-12-20 AU AU2005326226A patent/AU2005326226B2/en not_active Ceased
- 2005-12-20 US US11/883,302 patent/US7662781B2/en active Active
- 2005-12-20 JP JP2007500440A patent/JPWO2006080171A1/ja active Pending
- 2005-12-20 KR KR1020077018048A patent/KR20070099013A/ko active Search and Examination
-
2008
- 2008-04-02 HK HK08103620.4A patent/HK1113463A1/xx unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08511263A (ja) * | 1993-06-15 | 1996-11-26 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 造血細胞の放出と可動化 |
JP2000157285A (ja) * | 1998-11-30 | 2000-06-13 | Kenji Obara | Ld78遺伝子群ケモカインとホモログペプチド |
JP2004194770A (ja) * | 2002-12-17 | 2004-07-15 | Okumura Yu-Ki Co Ltd | 遊技機 |
Non-Patent Citations (7)
Title |
---|
DEMARIA S. ET AL.: "Ionizing Radiation Inhibition of Distant Untreated Tumors (Abscopal Effect) is Immune Mediated", INT. J. RADIAT. ONCOL. BIOL. PHYS., vol. 58, no. 3, 2004, pages 862 - 870, XP003000538 * |
GAZZANIGA S. ET AL.: "Inflammatory Changes after Cryosurgery-Induced Necrosis in Human Melanoma Xenografted in Nude Mice", J. INVEST. DERMATOL., vol. 116, no. 5, 2001, pages 664 - 671, XP003000539 * |
HORIUCHI T. ET AL.: "Abscopal effect o Mitometa Shocho NK/T Saibo Lymphoma", RINSHO KETSUEKI, vol. 44, no. 9, 2003, pages 940 - 945, XP002985649 * |
MENTEN P. ET AL.: "Macrophage inflammatory protein-1", CYTOKINE GROWTH FACTOR REV., vol. 13, 2002, pages 455 - 481, XP003000537 * |
See also references of EP1854474A4 * |
TARUKI C. ET AL.: "Mobilization of Dendritic Cells Into Solid Tumour by Administration of Styrene-maleic acid (SMA) Copolymer Conjugated MIP-1alpha(SMIP) in Mice", SEIKAGAKU, vol. 76, no. 8, 25 August 2004 (2004-08-25), pages 986, 3P-650, XP003000536 * |
WU F. ET AL.: "Activated Anti-tumor Immunity in Cancer Patients after High Intensity Focused Ultrasound Ablation", ULTRASOUND IN MED. & BIOL., vol. 30, no. 9, September 2004 (2004-09-01), pages 1217 - 1222, XP004646300 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | eMIPを有効成分とする水溶性製剤 |
Also Published As
Publication number | Publication date |
---|---|
CN101119743A (zh) | 2008-02-06 |
EP1854474A1 (en) | 2007-11-14 |
JPWO2006080171A1 (ja) | 2008-06-19 |
AU2005326226A1 (en) | 2006-08-03 |
CN101119743B (zh) | 2012-09-26 |
CA2596232A1 (en) | 2006-08-03 |
KR20070099013A (ko) | 2007-10-08 |
US7662781B2 (en) | 2010-02-16 |
US20090054318A1 (en) | 2009-02-26 |
HK1113463A1 (en) | 2008-10-03 |
AU2005326226B2 (en) | 2010-11-11 |
EP1854474A4 (en) | 2012-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhao et al. | In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy | |
JPH07509223A (ja) | インターロイキン−1媒介疾患および腫瘍壊死因子媒介疾患の治療方法 | |
AU2007200363B2 (en) | Colloidal metal compositions and methods | |
WO1997046260A1 (en) | Drug complexes | |
EA004791B1 (ru) | Композиции на основе слитого белка ob и способы их применения | |
JP2009287036A (ja) | 薬物複合体 | |
JPH09508141A (ja) | ビタミンb▲下12▼とタンパク質との複合体 | |
HU230160B1 (hu) | Interleukin-I inhibitort és kontrollált felszabadulású polimerként hialuronant tartalmazó készítmények | |
KR20150121715A (ko) | Csf1 치료제 | |
JPS60193924A (ja) | トランスフエリン‐ビンカアルカロイド細胞毒性組成物 | |
EP2650309A1 (en) | Conjugate of folate and antibody, preparation method and use thereof | |
WO2008083615A1 (fr) | Complexes comprenant de l'angiostatine et ses fragments, leurs procédés de préparation et leurs utilisations | |
JP2511159B2 (ja) | 免疫欠損状態の治療のための医薬製剤 | |
WO2001079302A1 (fr) | Combinaison d'acide folique et de polysaccharide, son procede de preparation et composition pharmaceutique contenant cette combinaison agissant comme principe actif | |
JP2022544481A (ja) | ポリペプチドまたはその誘導体の応用 | |
EP3169348B1 (en) | Pharmaceutical compositions comprising agonists of orexin-1 receptor ox1r for the treatment of inflammatory bowel diseases | |
WO2006080171A1 (ja) | 免疫増強剤 | |
JP2023504287A (ja) | 三分岐n-アセチルガラクトサミン修飾ヒドロキシルポリアミドアミンデンドリマーおよびその使用方法 | |
JPH0585942A (ja) | インターフエロン−ヒアルロン酸及び/又はその塩の結合体 | |
US20100021442A1 (en) | Method for promoting immunotherapy using an agent for elevating dendritic cell precursor level in blood | |
JP2545729B2 (ja) | メトトレキセート誘導体とピラン共重合体の高分子結合体及びその製造方法 | |
JP3522798B2 (ja) | 糖修飾蛋白質の製造法 | |
JPH0341478B2 (ja) | ||
JP2005281302A (ja) | 修飾インターロイキン−11及びそれを含有する医薬組成物 | |
Li et al. | Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005326226 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007500440 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2596232 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11883302 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580047524.5 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077018048 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2005326226 Country of ref document: AU Date of ref document: 20051220 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005326226 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005819441 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005819441 Country of ref document: EP |